X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Pfizer, Inc., left, and of Teva Pharmaceuticals USA Inc., right. The drug companies had fought to prevent details of the lawsuit from becoming public, but a federal judge granted the states’ motion to unseal the complaint. (Photo: Shutterstock.com)

A newly unredacted antitrust lawsuit against individual defendants and 20 corporate makers of generic drugs reveals details of how the pharmaceutical companies allegedly conspired to fix prices on more than 100 medications.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.